These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24622445)

  • 1. Ertapenem versus ceftriaxone for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
    Bai N; Sun C; Wang J; Cai Y; Liang B; Zhang L; Liu Y; Wang R
    Chin Med J (Engl); 2014; 127(6):1118-25. PubMed ID: 24622445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: ertapenem for complicated intra-abdominal infections.
    Falagas ME; Peppas G; Makris GC; Karageorgopoulos DE; Matthaiou DK
    Aliment Pharmacol Ther; 2008 May; 27(10):919-31. PubMed ID: 18266994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
    An MM; Zou Z; Shen H; Zhang JD; Chen ML; Liu P; Wang R; Jiang YY
    BMC Infect Dis; 2009 Dec; 9():193. PubMed ID: 19951447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
    Gesser RM; McCarroll K; Teppler H; Woods GL
    J Antimicrob Chemother; 2003 May; 51(5):1253-60. PubMed ID: 12697633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study.
    Tomera KM; Burdmann EA; Reyna OG; Jiang Q; Wimmer WM; Woods GL; Gesser RM;
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2895-900. PubMed ID: 12183244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults.
    Jimenez-Cruz F; Jasovich A; Cajigas J; Jiang Q; Imbeault D; Woods GL; Gesser RM;
    Urology; 2002 Jul; 60(1):16-22. PubMed ID: 12100914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of ertapenem.
    Teppler H; Gesser RM; Friedland IR; Woods GL; Meibohm A; Herman G; Mistry G; Isaacs R
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii75-81. PubMed ID: 15150186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial.
    Park DW; Peck KR; Chung MH; Lee JS; Park YS; Kim HY; Lee MS; Kim JY; Yeom JS; Kim MJ
    J Korean Med Sci; 2012 May; 27(5):476-83. PubMed ID: 22563210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of body mass index on treatment of complicated intra-abdominal infections in hospitalized adults: comparison of ertapenem with piperacillin-tazobactam.
    Zakrison TL; Hille DA; Namias N
    Surg Infect (Larchmt); 2012 Feb; 13(1):38-42. PubMed ID: 22217196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
    Ortiz-Ruiz G; Caballero-Lopez J; Friedland IR; Woods GL; Carides A;
    Clin Infect Dis; 2002 Apr; 34(8):1076-83. PubMed ID: 11914996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ceftazidime-avibactam in the treatment of complicated intra-abdominal infections (CIAIs) and complicated urinary tract infections (CUTIs): A meta-analysis of randomized controlled trials.
    Zhang Y; Tao LN; Qu XY; Niu JQ; Ding YH; Zhang SX
    Rev Assoc Med Bras (1992); 2018 Mar; 64(3):253-263. PubMed ID: 29641778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study.
    De Waele JJ; Tellado JM; Alder J; Reimnitz P; Jensen M; Hampel B; Arvis P
    Int J Antimicrob Agents; 2013 Jan; 41(1):57-64. PubMed ID: 23153963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults.
    Yellin AE; Hassett JM; Fernandez A; Geib J; Adeyi B; Woods GL; Teppler H;
    Int J Antimicrob Agents; 2002 Sep; 20(3):165-73. PubMed ID: 12385694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxifloxacin monotherapy for treatment of complicated intra-abdominal infections: a meta-analysis of randomised controlled trials.
    Mu YP; Liu RL; Wang LQ; Deng X; Zhu N; Wei MD; Wang Y
    Int J Clin Pract; 2012 Feb; 66(2):210-7. PubMed ID: 22257046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis.
    Grau S; Lozano V; Valladares A; Cavanillas R; Xie Y; Nocea G
    Appl Health Econ Health Policy; 2015 Aug; 13(4):369-79. PubMed ID: 25761545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies.
    Ortiz-Ruiz G; Vetter N; Isaacs R; Carides A; Woods GL; Friedland I
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii59-66. PubMed ID: 15150184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia.
    Vetter N; Cambronero-Hernandez E; Rohlf J; Simon S; Carides A; Oliveria T; Isaacs R;
    Clin Ther; 2002 Nov; 24(11):1770-85. PubMed ID: 12501873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ertapenem therapy for community-acquired pneumonia in the elderly.
    Woods GL; Isaacs RD; McCarroll KA; Friedland IR
    J Am Geriatr Soc; 2003 Nov; 51(11):1526-32. PubMed ID: 14687380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.